1. Home
  2. VRNA vs BILI Comparison

VRNA vs BILI Comparison

Compare VRNA & BILI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • BILI
  • Stock Information
  • Founded
  • VRNA 2005
  • BILI 2009
  • Country
  • VRNA United Kingdom
  • BILI China
  • Employees
  • VRNA N/A
  • BILI N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • BILI EDP Services
  • Sector
  • VRNA Health Care
  • BILI Technology
  • Exchange
  • VRNA Nasdaq
  • BILI Nasdaq
  • Market Cap
  • VRNA 8.3B
  • BILI 8.8B
  • IPO Year
  • VRNA 2017
  • BILI 2018
  • Fundamental
  • Price
  • VRNA $106.27
  • BILI $27.39
  • Analyst Decision
  • VRNA Buy
  • BILI Buy
  • Analyst Count
  • VRNA 11
  • BILI 6
  • Target Price
  • VRNA $114.10
  • BILI $26.00
  • AVG Volume (30 Days)
  • VRNA 1.3M
  • BILI 4.0M
  • Earning Date
  • VRNA 11-03-2025
  • BILI 11-13-2025
  • Dividend Yield
  • VRNA N/A
  • BILI N/A
  • EPS Growth
  • VRNA N/A
  • BILI N/A
  • EPS
  • VRNA N/A
  • BILI 0.07
  • Revenue
  • VRNA $221,673,000.00
  • BILI $4,101,275,719.00
  • Revenue This Year
  • VRNA $896.59
  • BILI $15.06
  • Revenue Next Year
  • VRNA $77.56
  • BILI $8.99
  • P/E Ratio
  • VRNA N/A
  • BILI $376.57
  • Revenue Growth
  • VRNA N/A
  • BILI 22.70
  • 52 Week Low
  • VRNA $27.54
  • BILI $14.36
  • 52 Week High
  • VRNA $106.45
  • BILI $31.77
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 68.40
  • BILI 71.39
  • Support Level
  • VRNA $106.15
  • BILI $23.70
  • Resistance Level
  • VRNA $106.42
  • BILI $27.64
  • Average True Range (ATR)
  • VRNA 0.19
  • BILI 0.72
  • MACD
  • VRNA -0.17
  • BILI 0.46
  • Stochastic Oscillator
  • VRNA 76.32
  • BILI 95.55

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About BILI Bilibili Inc.

Bilibili is a Chinese online entertainment platform best known for its YouTube-like video-sharing site. Founded in 2009, it initially focused on long-form content centered around anime, comics, and gaming, catering primarily to Gen Z users. Over time, the platform has broadened its content offerings to include a wider range of interests, successfully attracting a more diverse audience beyond the Gen Z demographic.

Share on Social Networks: